PMID- 36219533 OWN - NLM STAT- MEDLINE DCOM- 20230103 LR - 20230707 IS - 1756-185X (Electronic) IS - 1756-1841 (Linking) VI - 26 IP - 1 DP - 2023 Jan TI - Screening of key biomarkers in osteoporosis: Evidence from bioinformatic analysis. PG - 69-79 LID - 10.1111/1756-185X.14450 [doi] AB - OBJECTIVE: To analyze the expression characteristics of osteoporosis-related genes by bioinformatics and elucidate the pathogenesis of osteoporosis. METHODS: The differentially expressed genes (DEGs), microRNA (miRNA), and genes with differentially methylated regions (DMRS) in promoters were identified. The protein-protein interaction (PPI) network was constructed and performed. The Clue Gene Ontology analysis and miRNA-mRNA (messenger RNA) regulatory network were constructed using Cytoscape. RESULTS: Fifty-nine DEGs, 10 differential miRNAs, and 2083 genes with DMRs were screened out. The Proteasome-Modulator (PSMD) family proteins and estrogen receptor 1 (ESR1) are vital for the PPI analysis of DEGs. The interaction network of the Smad3 protein showed that the degree of connection to ESR1, PSMD11, and transcription factor 4 (TCF4) is very high. Homo sapiens (hsa)-miR-106b-5p was differential and regulated TCF4 through building the miRNA-mRNA regulatory network. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment of DEGs focused on vascular smooth muscle contraction, thyroid hormone signaling pathway, and estrogen signaling pathway. The Gene Ontology (GO) function analysis of genes with DMRs in promoters was primarily concentrated in the cell differentiation, positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity, and positive regulation of C-palmitoyltransferase activity. The KEGG enrichment of genes with DMRs in promoters largely focused on glycerol phospholipid metabolism, histidine metabolism, Adenosine 5'-monophosphate-activated protein kinase signaling pathway, Hedgehog signaling pathway, and mRNA surveillance pathway. CONCLUSION: Hsa-miRNA-106b-5p regulates bone formation and the pathogenesis of osteoporosis by controlling TCF4, and methylation modification of TCF4 can also affect the pathogenesis of osteoporosis. CI - (c) 2022 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd. FAU - Chen, Hao AU - Chen H AD - Traditional Chinese Medicine Orthopedics, Nanjing University of Chinese Medicine, Nanjing, China. AD - Department of Orthopedics and Traumatology, Yancheng Dafeng Hospital of Traditional Chinese Medicine, Yancheng, China. FAU - Li, Shaoshuo AU - Li S AD - Traditional Chinese Medicine Orthopedics, Nanjing University of Chinese Medicine, Nanjing, China. FAU - Wang, Jianwei AU - Wang J AD - Department of Orthopedics, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, China. FAU - Ma, Yong AU - Ma Y AD - Traditional Chinese Medicine Orthopedics, Nanjing University of Chinese Medicine, Nanjing, China. FAU - Yin, Heng AU - Yin H AUID- ORCID: 0000-0001-9081-1082 AD - Department of Orthopedics, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, China. LA - eng GR - BJ2020063/Top Talent Support Program for young and middle-aged people of Wuxi Health Committee/ GR - BK20180167/Jiangsu Natural Science Foundation/ GR - 81973878/National Natural Science Foundation of China/ GR - 81873320/National Natural Science Foundation of China/ PT - Journal Article DEP - 20221011 PL - England TA - Int J Rheum Dis JT - International journal of rheumatic diseases JID - 101474930 RN - 0 (Hedgehog Proteins) RN - 0 (MicroRNAs) RN - 0 (Biomarkers) RN - 0 (RNA, Messenger) SB - IM CIN - Int J Rheum Dis. 2023 Jul;26(7):1220-1221. PMID: 37394890 MH - Humans MH - Gene Regulatory Networks MH - Gene Expression Profiling MH - Hedgehog Proteins MH - *MicroRNAs/genetics/metabolism MH - Biomarkers MH - Computational Biology MH - *Osteoporosis/diagnosis/genetics MH - RNA, Messenger/genetics/metabolism OTO - NOTNLM OT - DNA methylation OT - Smad3 OT - bioinformatics OT - mRNA OT - microRNA OT - osteoporosis EDAT- 2022/10/12 06:00 MHDA- 2023/01/04 06:00 CRDT- 2022/10/11 12:14 PHST- 2022/09/02 00:00 [revised] PHST- 2022/06/07 00:00 [received] PHST- 2022/09/20 00:00 [accepted] PHST- 2022/10/12 06:00 [pubmed] PHST- 2023/01/04 06:00 [medline] PHST- 2022/10/11 12:14 [entrez] AID - 10.1111/1756-185X.14450 [doi] PST - ppublish SO - Int J Rheum Dis. 2023 Jan;26(1):69-79. doi: 10.1111/1756-185X.14450. Epub 2022 Oct 11.